The Oncology Companion Diagnostic Market was valued at USD 4.12 billion in 2023 and is on a trajectory to reach USD 10.60 billion by 2032. This remarkable expansion, forecasted to occur at a compound annual growth rate (CAGR) of 11.09% during the period 2024-2032, highlights the growing significance of companion diagnostics in oncology. With the increasing demand for personalized medicine and ta..